Xiao W. Huan

No.12 Middle Wulumuqi Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia.

Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia.

Journal: Infection and drug resistance

Published: December 15, 2025

Good's syndrome and infections in a large retrospective cohort of thymoma.

Good's syndrome and infections in a large retrospective cohort of thymoma.

Journal: Frontiers in immunology

Published: October 27, 2025

Targeting pathogenic Th17.1 cells via JAK-STAT3 pathway: A novel approach with tofacitinib for refractory myasthenia gravis.

Targeting pathogenic Th17.1 cells via JAK-STAT3 pathway: A novel approach with tofacitinib for refractory myasthenia gravis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 11, 2025

1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China.

1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China.

Journal: European journal of neurology

Published: October 06, 2025

Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study.

Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 05, 2025

The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit.

The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit.

Journal: Neurocritical care

Published: May 14, 2025

Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis.

Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis.

Journal: Frontiers in immunology

Published: February 17, 2025

Impact of COVID-19 pandemic on the implementation of transmission-based precautions.

Impact of COVID-19 pandemic on the implementation of transmission-based precautions.

Journal: The Journal of hospital infection

Published: December 05, 2024

Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study.

Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study.

Journal: Therapeutic advances in neurological disorders

Published: August 06, 2024

Nomogram for predicting pregnancy-related relapse of myasthenia gravis.

Nomogram for predicting pregnancy-related relapse of myasthenia gravis.

Journal: Orphanet journal of rare diseases

Published: July 02, 2024

Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study.

Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study.

Journal: Journal of neuroimmunology

Published: June 19, 2024

Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.

Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.

Journal: Frontiers in immunology

Published: April 16, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026